Can a patient have atrioventricular re‑entrant tachycardia (AVRT) without Wolff‑Parkinson‑White (WPW) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Have AVRT Without WPW Syndrome?

Yes, patients can absolutely have atrioventricular re-entrant tachycardia (AVRT) without Wolff-Parkinson-White (WPW) syndrome—this occurs when the accessory pathway conducts only retrogradely (concealed accessory pathway) and does not produce ventricular pre-excitation on the baseline ECG. 1, 2

Understanding the Key Distinction

The critical difference lies in the direction of conduction through the accessory pathway:

  • WPW syndrome requires both a manifest accessory pathway (producing the characteristic short PR interval and delta wave on ECG during sinus rhythm) plus documented supraventricular tachycardia or SVT-consistent symptoms 1, 2, 3

  • AVRT without WPW occurs when patients have a concealed accessory pathway that conducts only in the retrograde direction (ventricle-to-atrium), so the baseline ECG appears completely normal during sinus rhythm 1, 2

Clinical Presentation & Mechanism

Orthodromic AVRT is the most common form of AVRT (accounting for 90-95% of cases) and typically presents with a narrow QRS complex because ventricular activation occurs through the normal AV node-His-Purkinje system in the antegrade direction, while the accessory pathway is used retrogradely. 3, 4 This mechanism works identically whether the accessory pathway is manifest (WPW) or concealed (non-WPW).

Key features of AVRT with concealed pathways:

  • The baseline ECG shows no pre-excitation pattern (normal PR interval, no delta wave) because the pathway cannot conduct anterogradely 1, 2
  • During tachycardia, the circuit uses the AV node anterogradely and the concealed pathway retrogradely 1, 2
  • Adenosine terminates orthodromic AVRT in approximately 95% of cases by blocking the AV node, which is part of the re-entrant circuit 3
  • The QRS complex during tachycardia is narrow unless there is pre-existing bundle branch block or aberrant conduction 1, 2

Diagnostic Approach

When evaluating a patient with suspected AVRT:

  • Obtain a 12-lead ECG during both sinus rhythm and tachycardia 5
  • Absence of pre-excitation on the baseline ECG does not exclude an accessory pathway—it only indicates the pathway is concealed 1, 2
  • Adenosine administration (6 mg rapid IV push, followed by 12 mg if needed) serves both diagnostic and therapeutic purposes in stable, regular, monomorphic wide-complex or narrow-complex tachycardias where the AV node is part of the circuit 5
  • The response to adenosine helps differentiate AVRT from other supraventricular tachycardias 5

Treatment Implications

The acute management of AVRT is similar regardless of whether the patient has manifest WPW or a concealed pathway:

  • For hemodynamically unstable patients, immediate synchronized cardioversion is warranted 5
  • For stable patients, vagal maneuvers followed by adenosine are first-line therapies 5, 3
  • Catheter ablation is now the treatment of choice for symptomatic AVRT, offering high acute success rates (93% for accessory pathway ablation) with low major complication rates (2.8%) 6, 7, 3

Critical Safety Considerations

A major pitfall is assuming that a normal baseline ECG (no pre-excitation) means the patient is at lower risk. Some concealed pathways can have short refractory periods and may still pose risks if atrial fibrillation develops, though this risk is generally lower than with manifest pathways 8

Never administer verapamil or diltiazem for wide-complex tachycardia of unknown etiology, as these agents can cause profound hypotension and cardiovascular collapse 5, 7, 3 This warning applies whether or not WPW is present.

Epidemiology & Natural History

  • AVNRT is more common in middle-aged or older patients, whereas AVRT may be more prevalent in adolescents, with the relative frequency of accessory pathway-mediated tachycardia decreasing with age 1
  • Among patients with manifest WPW, orthodromic AVRT accounts for 95% of re-entrant tachycardias 4
  • Concealed accessory pathways represent a significant proportion of AVRT cases, particularly in patients without visible pre-excitation on baseline ECG 1, 2

The bottom line: AVRT is defined by the presence of an accessory pathway in the re-entrant circuit—not by whether that pathway produces visible pre-excitation on the baseline ECG. Concealed pathways conducting only retrogradely are a well-recognized cause of AVRT in patients who never demonstrate WPW syndrome.

References

Guideline

Management of WPW Syndrome and AVRT in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

WPW and preexcitation syndromes.

The Journal of the Association of Physicians of India, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.